Parkinson Disease Clinical Trials in Portland, Oregon

7 studies are recruiting for parkinson disease in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

   A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.

   Stage

   Phase 2

   Ages

   40 to 80

   Site

   Site-091, Portland, Oregon

   Locations

   22 in total

   Run by

   Biohaven Therapeutics Ltd.

   See if you can join NCT06976268 on ClinicalTrials.gov

2. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

   The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

   Stage

   Phase 2

   Ages

   40 to 80

   Site

   Oregon Health & Science University (OHSU), Portland, Oregon

   Locations

   72 in total

   Run by

   Neuron23 Inc.

   See if you can join NCT06680830 on ClinicalTrials.gov

3. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

   The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

   Stage

   Not phased

   Ages

   30 and older

   Site

   Oregon Health &Science University, Portland, Oregon

   Locations

   50 in total

   Run by

   Michael J. Fox Foundation for Parkinson's Research

   See if you can join NCT04477785 on ClinicalTrials.gov

4. Balance Tele-Rehab in Parkinson's Disease

   This project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.

   Stage

   Not phased

   Ages

   55 to 85

   Site

   Oregon Health Science University, Portland, Oregon

   Run by

   Oregon Health and Science University

   See if you can join NCT05680597 on ClinicalTrials.gov

5. Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

   The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease. The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkins…

   Stage

   Not phased

   Ages

   40 to 99

   Site

   Oregon Health & Science University, Portland, Oregon

   Run by

   CND Life Sciences

   See if you can join NCT07204652 on ClinicalTrials.gov

6. Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

   The purpose of the study is to determine the effects of a novel, personalized, tactile cueing system on gait automaticity. The researchers hypothesized that step-synchronized tactile cueing will reduce prefrontal cortex activity (improve automaticity) and improve gait variability (as well as gait s…

   Stage

   Not phased

   Ages

   45 to 85

   Site

   Oregon Health and Science University, Portland, Oregon

   Run by

   Oregon Health and Science University

   See if you can join NCT05818189 on ClinicalTrials.gov

7. TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

   The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention…

   Stage

   Not phased

   Ages

   50 to 80

   Site

   Oregon Health and Science University, Portland, Oregon

   Locations

   3 in total

   Run by

   Oregon Health and Science University

   See if you can join NCT06815302 on ClinicalTrials.gov